Virtual Conference Overview

 

To further support science in the fight against SARS-CoV-2, Thermo Fisher Scientific is hosting a virtual conference featuring leading experts from around the world.

Join us for the free ‘Science Against SARS-CoV-2’ virtual conference which will bring together scientific experts from multiple fields to present their current knowledge and the future strategies they are adopting to help understand the following:

  • SARS-CoV-2 pathogen-host biology
  • The route to developing effective vaccines and therapeutics
  • Current and emerging viral detection methods
  • Monitoring the virus spread globally

Over the 3-day event, the perspectives of key thought leaders will be shared in a mix of presentations, discussion panels and Q&A sessions. This will provide a forum for international discussion, with experts presenting and discussing current challenges and lessons learned to facilitate an exchange of scientific knowledge and encourage collaboration.

 

Conference Agenda

 

Dissecting Host-pathogen Biology and Interactions

The first day of the meeting will bring together research experts to present our current knowledge, strategies and approaches to research SARS-CoV-2 biology and impact on the host. Talks will cover different aspects of pathogen/host interaction including newest insights on immune response and induction of cytokine storm upon infection, as well as recent findings on SARS-CoV-2 inhibiting pathways and potential antiviral compounds. We will also discuss future perspectives in infection disease research.

Register now ›

Time (CET) Speaker Presentation
11:00 - 11:15 Claire Wallace  Introduction
11:15 - 12:05 Dr. Andrea Cossarizza, M.D. "Immune system and COVID-19"
12:05 - 12:20   Break
12:20 - 12:45 Dr. Montserrat Barcena 'Cellular cryotomography unravels a missing link in coronavirus replication'
12:45 - 13:10 Timothée Bruel, PhD A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human samples from different populations
13:10 - 13:35 Pauline Maisonnasse, PhD "Evaluation of hydroxychloroquine as a treatment in SARS-CoV-2 infection"
13:35 - 14:20   Lunch
14:20 - 14:45 Steeve Boulant, PhD "Understanding the importance of the SARS-CoV-2 enteric phase using human intestinal organoids"
14:45 - 15:10 Dr. Vibor Laketa "Advanced Microscopy Approaches Reveal Key Aspects of SARS-CoV-2 Biology "
15:10 - 15:20   Closing remarks

Vaccine & Therapeutic Development Strategies

There are a number of vaccine candidates currently under investigation and in various stages of development, some anti-viral drug or biologic based approaches have even been approved for emergency or compassionate use. During day 2 of the conference you will hear from a panel of experts on a variety of strategies for vaccine and therapeutic development to prevent and treat this global pandemic.

Register now ›

Time (CET) Speaker Presentation
11:00 - 11:15 Ashley Box Introduction
11:15 - 11:40 Prof. Carl S. Goodyear  What can B cell repertoire analysis tell us about response to COVID-19?
11:40 - 12:05 Dr. Olivier Demaria Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis
12:05 - 12:30 Dr. Zania Stamataki Title to be confirmed
12:30 - 13:30   Lunch
13:30 - 13:55 Dr. Peter Scheinert Title to be confirmed
13:55 - 14:20 Dr. Anil Kane Drug Repurposing Trends Through the Eyes of a Global CDMO  
14:20 - 14:30 Group Round table discussion and closing remarks

Detection Techniques and Epidemiology Studies for SARS-CoV-2 infection

On the final day of the conference, choose from two sessions to hear from experts in the fields of virus detection and epidemiology research. In the viral detection session, topics include the wide variety of techniques being employed to detect the virus. In the epidemiology session, join talks about viral surveillance in wastewater, human host genetics and virus evolution and epidemiology.

Register now ›

Time (CET) Speaker Presentation
11:00-11:15 To be confirmed Introduction
11:15 - 11:40 To be confirmed LAMP technologies for SARS-CoV2- detection
11:40 - 12:05 To be confirmed Title to be confirmed
12:05 -12:15   Break
12:15 - 12:40 Dr Jason Potter Using CRISPR enzymes for SARS-CoV2- detection
12:40 - 13:05 Dr.- Ing. Shelesh Agrawal The role of the wastewater-based epidemiology at the time of the COVID-19 pandemic
13:05-13:50   Lunch
13:50-14:15 Dr. Luca Quagliata, PhD, BCMAS Introduction in epidemiology
14:15-15:00 Dr. Barbara Bartolini Evolutionary trajectories of SARS-CoV-2 and laboratories challenges
15:00-15:10   Break
15:10-15:35 To be confirmed To be confirmed
15:35-16:00 Dr. Luisa Pereira Integrated approach of virus sequencing and host genetics in a Covid-19 North Portuguese cohort
16:00-16:10 Claire Wallace Close

This is a scientific conference discussing the scientific aspects behind SARS-CoV-2

It is aimed at researchers, scientific officers, scientific leads, and laboratory staff involved with SARS-CoV-2 research, vaccine discovery and development, and detection and epidemiology.

Register now ›

Dissecting Host-pathogen Biology and Interactions

The first day of the meeting will bring together research experts to present our current knowledge, strategies and approaches to research SARS-CoV-2 biology and impact on the host. Talks will cover different aspects of pathogen/host interaction including newest insights on immune response and induction of cytokine storm upon infection, as well as recent findings on SARS-CoV-2 inhibiting pathways and potential antiviral compounds. We will also discuss future perspectives in infection disease research.

Register now ›

Time (CET) Speaker Presentation
11:00 - 11:15 Claire Wallace  Introduction
11:15 - 12:05 Dr. Andrea Cossarizza, M.D. "Immune system and COVID-19"
12:05 - 12:20   Break
12:20 - 12:45 Dr. Montserrat Barcena 'Cellular cryotomography unravels a missing link in coronavirus replication'
12:45 - 13:10 Timothée Bruel, PhD A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human samples from different populations
13:10 - 13:35 Pauline Maisonnasse, PhD "Evaluation of hydroxychloroquine as a treatment in SARS-CoV-2 infection"
13:35 - 14:20   Lunch
14:20 - 14:45 Steeve Boulant, PhD "Understanding the importance of the SARS-CoV-2 enteric phase using human intestinal organoids"
14:45 - 15:10 Dr. Vibor Laketa "Advanced Microscopy Approaches Reveal Key Aspects of SARS-CoV-2 Biology "
15:10 - 15:20   Closing remarks

Vaccine & Therapeutic Development Strategies

There are a number of vaccine candidates currently under investigation and in various stages of development, some anti-viral drug or biologic based approaches have even been approved for emergency or compassionate use. During day 2 of the conference you will hear from a panel of experts on a variety of strategies for vaccine and therapeutic development to prevent and treat this global pandemic.

Register now ›

Time (CET) Speaker Presentation
11:00 - 11:15 Ashley Box Introduction
11:15 - 11:40 Prof. Carl S. Goodyear  What can B cell repertoire analysis tell us about response to COVID-19?
11:40 - 12:05 Dr. Olivier Demaria Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis
12:05 - 12:30 Dr. Zania Stamataki Title to be confirmed
12:30 - 13:30   Lunch
13:30 - 13:55 Dr. Peter Scheinert Title to be confirmed
13:55 - 14:20 Dr. Anil Kane Drug Repurposing Trends Through the Eyes of a Global CDMO  
14:20 - 14:30 Group Round table discussion and closing remarks

Detection Techniques and Epidemiology Studies for SARS-CoV-2 infection

On the final day of the conference, choose from two sessions to hear from experts in the fields of virus detection and epidemiology research. In the viral detection session, topics include the wide variety of techniques being employed to detect the virus. In the epidemiology session, join talks about viral surveillance in wastewater, human host genetics and virus evolution and epidemiology.

Register now ›

Time (CET) Speaker Presentation
11:00-11:15 To be confirmed Introduction
11:15 - 11:40 To be confirmed LAMP technologies for SARS-CoV2- detection
11:40 - 12:05 To be confirmed Title to be confirmed
12:05 -12:15   Break
12:15 - 12:40 Dr Jason Potter Using CRISPR enzymes for SARS-CoV2- detection
12:40 - 13:05 Dr.- Ing. Shelesh Agrawal The role of the wastewater-based epidemiology at the time of the COVID-19 pandemic
13:05-13:50   Lunch
13:50-14:15 Dr. Luca Quagliata, PhD, BCMAS Introduction in epidemiology
14:15-15:00 Dr. Barbara Bartolini Evolutionary trajectories of SARS-CoV-2 and laboratories challenges
15:00-15:10   Break
15:10-15:35 To be confirmed To be confirmed
15:35-16:00 Dr. Luisa Pereira Integrated approach of virus sequencing and host genetics in a Covid-19 North Portuguese cohort
16:00-16:10 Claire Wallace Close

This is a scientific conference discussing the scientific aspects behind SARS-CoV-2

It is aimed at researchers, scientific officers, scientific leads, and laboratory staff involved with SARS-CoV-2 research, vaccine discovery and development, and detection and epidemiology.

Register now ›

 

Speakers

 

Cossarizza

Dr. Andrea Cossarizza, M.D.

University of Modena and Reggio Emilia School of Medicine, Modena, Italy
Immune system and COVID-19

Day 1 | 11:15–12:05


Barcena

Dr. Montserrat Barcena

Assistant Professor, EM section, Department of Cell and Chemical Biology, Leiden University Medical Center (LUMC)
Cellular cryotomography unravels a missing link in coronavirus replication

Day 1 | 12:20 - 12:45


Bruel

Timothée Bruel, Ph.D.

Staff Scientist, Institut Pasteur
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human samples from different populations

Day 1 | 12:45 - 13:10


Maisonnasse

Pauline Maisonnasse, Ph.D.

Project manager in immunology/vaccinology, CEA – IDMIT
Evaluation of hydroxychloroquine as a treatment in SARS-CoV-2 infection

Day 1 | 13:10 - 13:35


Boulant

Steeve Boulant, PhD

Group leader, Heidelberg University/Department of Infectious Diseases
Understanding the importance of the SARS-CoV-2 enteric phase using human intestinal organoids

Day 1 | 14:30 - 14:55

Laketa

Dr. Vibor Laketa

Head of Infectious Diseases Imaging Platform,  Center for Integrative Infectious Disease Research, University Hospital Heidelberg
Advanced Microscopy Approaches Reveal Key Aspects of SARS-CoV-2 Biology

Day 1 | 14:55 - 15:20

 

Goodyear

Prof. Carl S. Goodyear

Director of GLAZgo Discovery Centre, College of Medical, Veterinary and Life Sciences, University of Glasgow
What can B cell repertoire analysis tell us about response to COVID-19?

Day 2 | 12:20 - 12:45

 

Demaria

Dr. Olivier Demaria

Science Leader, Drug Discovery, Innate Pharma, France
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis

Day 2 | 14:55–15:20

 

Kane

Dr. Anil Kane

Executive Director, Global Head of Technical & Scientific Affairs, Thermo Fisher Scientific
Drug Repurposing Trends Through the Eyes of a Global CDMO

Day 2 | 15:20–15:50

 

Potter

Jason Potter

Senior R&D Scientist, Thermo Fisher Scientific, Carlsbad, California
Using CRISPR enzymes for SARS-CoV2- Detection

Day 3 | 12:30 - 12:55

 

Shelesh

Dr. Ing. Shelesh Agrawal

Microbiology Group Leader, Technical University of Darmstadt
Institut IWAR, Germany
The role of the wastewater-based epidemiology at the time of the COVID-19 pandemic

Day 3 | 12:55 - 13:20


Bartolini

Dr. Barbara Bartolini

Senior Scientist at Microbiology Laboratory and Infectious Diseases Biorepository at the National Institute for Infectious Diseases “L. Spallanzani” (INMI), Rome, Italy
Evolutionary trajectories of SARS-CoV-2 and laboratories challenges 

Day 3 | 14:30-15:20

 

Pereira

Dr. Luisa Pereira

Principal Researcher & Group Leader, i3S-IPATIMUP
Integrated approach of virus sequencing and host genetics in a Covid-19 North Portuguese cohort

Day 3 | 15:55-16:20

 

Facts and statistics on SARS-CoV-2

 

 

Explore all of our SARS-CoV-2 tools and solutions

 

 

Thermo Fisher Scientific's SARS-CoV-2 Global Response

 

We remain dedicated to the global fight against SARS-CoV-2

We are here to support researchers and scientists across the globe who are working to develop treatments and vaccines for SARS-CoV-2. Now, more than ever, we remain steadfast in our mission to make the world healthier, cleaner, and safer.

Trust that our team of experts is here to address your individual product needs and offer remote support for your SARS-CoV-2 research.

With an ability to conduct remote instrument support and quickly scale development and production, Thermo Fisher Scientific provides the products and support needed to keep your lab running even in areas where travel is restricted.

View SARS-CoV-2 FAQs, news, and resources from Thermo Fisher Scientific

Style Sheet for Global Design System
Style Sheet for Komodo Tabs